Texas lab owner accused of Rs 800 crore Medicare fraud, may be in Hyderabad
US federal officials have accused Khadeer Khan Mohammed (46), owner of American Premier Labs LLC in Richardson, Texas, of submitting about $93 million (over Rs 800 crore) in false genetic testing claims to Medicare between August 2023 and October 2024. Medicare paid at least $63 million, and about $6 million was seized from his accounts. Placed on a fugitive list, he is reportedly in Hyderabad. The case remains pending in court.
Source
హైదరాబాద్ — Hyderabad · read the original report ↗
Desk check · some claims need care
What the desk checked (5)
- American Premier Labs LLC owner Khadeer Khan Mohammed (46) of Richardson, Texas submitted about $93 million in false genetic testing claims between August 2023 and October 2024. — Attributed to US federal officials in the source; figure appears in source; no case number or agency named.
- Medicare paid at least $63 million of those claims. — Attributed to officials in the source; no independent documentation cited.
- About $13 million in claims were submitted within a 10-day period, and roughly $6 million was seized from bank accounts under his control. — Both figures attributed to officials; internally consistent with the total cited.
- He has been placed on a most-wanted fugitive list and is reportedly in Hyderabad after fleeing the US. — Source says officials received information about his location; presence in Hyderabad is unconfirmed.
- Police are monitoring arrivals from Shamshabad airport into the city. — Stated in source without named police official or department.
Analysts’ view opinion
ఇది ప్రస్తుతానికి ఆరోపణల దశలో ఉన్న ఫెడరల్ కేసు — అమెరికా అధికారులు ఆరోపణలు నమోదు చేశారు, కానీ కోర్టులో నేరనిర్ధారణ జరగలేదని కథనం స్పష్టంగా చెబుతోంది; అందువల్ల 'నిర్దోషిత్వ ఊహ' (presumption of innocence) ఇక్కడ కేవలం మర్యాద కాదు, చట్టపరమైన ప్రమాణం. నిందితుడు భారత్‌లో ఉన్నట్లు సమాచారం ఉన్నందున, ఈ కేసు తక్షణ కీలక ప్రశ్న నేరనిరూపణ కాదు — అధికార పరిధి, అప్పగింత (extradition) ప్రక్రియ. ఇండో-యూఎస్ అప్పగింత ఒప్పందం ఉన్నప్పటికీ, ఇది కోర్టు ద్వారా జరిగే సుదీర్ఘ ప్రక్రియ; ఏకపక్షంగా ఎవరినీ తరలించలేరు.
- ఆరోపణపత్రం (charges) అంటే సాక్ష్యం రుజువైనట్లు కాదు; ఫెడరల్ ప్రాసిక్యూషన్‌లో నేరం 'సందేహాతీతంగా' నిరూపించే భారం పూర్తిగా ప్రభుత్వానిదే.
- ఆరోపణల స్వభావం — వైద్యులు ఆదేశించని పరీక్షలకు క్లెయిమ్‌లు, వైద్యుల గుర్తింపు సమాచార దుర్వినియోగం — సాధారణంగా హెల్త్‌కేర్ ఫ్రాడ్, వైర్ ఫ్రాడ్, ఐడెంటిటీ మిస్‌యూజ్ వంటి బహుళ అభియోగాల పరిధిలోకి వస్తాయి; అయితే ఖచ్చితమైన అభియోగ జాబితా ఈ కథనంలో పేర్కొనలేదు.
- స్వాధీనం చేసుకున్న 6 మిలియన్ డాలర్లు నేరనిర్ధారణకు ముందు జరిగే సివిల్/క్రిమినల్ ఫోర్‌ఫీచర్ ప్రక్రియకు లోబడి ఉంటుంది — ఇది క్రిమినల్ ట్రయల్‌కు సమానాంతరంగా, వేరుగా నడిచే వ్యవహారం.
- 'ఫ్యుజిటివ్' హోదా, హైదరాబాద్‌లో ఉన్నట్లు సమాచారం ఉన్నందున — ఇంటర్‌పోల్ నోటీసు, భారత అధికారుల సహకారం, అప్పగింత అభ్యర్థనపై భారత కోర్టు విచారణ అనే దశలు అనుసరించాల్సి ఉంటుంది.
- భారత పౌరసత్వం, ద్వంద్వ నేరత్వం (dual criminality) వంటి అంశాలపై అప్పగింత తీవ్రంగా ఆధారపడుతుంది; అలాగే నిందితుడికి భారత కోర్టుల్లో ప్రతివాదన హక్కు, అప్పీలు హక్కు ఉంటాయి.
What to watch — అమెరికా అధికారికంగా అప్పగింత అభ్యర్థన సమర్పించారా, భారత అధికారులు లుక్‌అవుట్/ఇంటర్‌పోల్ ప్రక్రియను ఎలా ముందుకు తీసుకెళ్తారు — మరియు ఆ ప్రక్రియ కోర్టు ముందుకు వస్తుందా అనే దానిపై దృష్టి పెట్టాలి.
నిందితుడు నిజంగా హైదరాబాద్‌లో ఉన్నారా, అధికారిక అప్పగింత అభ్యర్థన సమర్పించారా, ఏ ఖచ్చితమైన అభియోగాలు నమోదయ్యాయి — ఈ ఏవీ ఈ కథనం నిర్ధారించలేదు; ఇది ఆరోపణలు, 'సమాచారం' స్థాయిలో మాత్రమే ఉంది.
Deep dive
Research brief · 8 facts · 4 dates · exam-readyThe brief
Context
Medicare is the US federal government-funded health insurance programme, and laboratories that bill it for tests are a recurring target of fraud investigations. US federal authorities have accused Khadeer Khan Mohammed (46), owner of American Premier Labs LLC, a genetic testing laboratory in Richardson, Texas, of submitting roughly $93 million (over Rs 800 crore) in false genetic testing claims to Medicare. Texas officials have placed him on a fugitive most-wanted list and have information that he fled the US and is in Hyderabad. The case is still pending in court and he has not been convicted; he is presumed innocent until guilt is proved.
Key facts
- US federal officials allege about $93 million (over Rs 800 crore) in false genetic testing claims were submitted to Medicare.
- The alleged false claims were submitted between August 2023 and October 2024.
- Medicare made payments on at least $63 million worth of those claims, officials said.
- Claims worth about $13 million linked to Mohammed were submitted within a span of just 10 days.
- About $6 million was seized during the investigation from bank accounts controlled by Mohammed.
- The accused is Khadeer Khan Mohammed, 46, owner of American Premier Labs LLC, Richardson, Texas.
- Officials allege doctors' personal identifying information was used without permission to file claims for beneficiaries unconnected to them.
- Texas authorities placed him on the fugitive most-wanted list; the case remains pending in court with no conviction so far.
Timeline
- August 2023 to October 2024Period in which about $93 million in allegedly false Medicare genetic testing claims were submitted.
- During the investigationAuthorities seized about $6 million from bank accounts controlled by Mohammed.
- SubsequentlyTexas officials added Khadeer Khan Mohammed to the fugitive most-wanted list; information received that he fled the US and is in Hyderabad.
- September 14 (report date)Case still pending in court; police keep watch on arrivals into the city from Shamshabad airport.
Who has a stake
- Khadeer Khan Mohammed (46), owner of American Premier Labs LLC — Accused of the fraud and on a fugitive list; not yet convicted and presumed innocent until proved guilty in court.
- US Medicare programme — Government-funded insurance that allegedly paid at least $63 million on false genetic testing claims.
- US federal officials and Texas investigators — Building the fraud case, recovering funds ($6 million seized) and tracing a fugitive abroad.
- Doctors whose identity details were allegedly misused — Their personal identifying information was allegedly used without consent to submit claims in their names.
- Medicare beneficiaries named in claims — Genetic tests billed in their names were allegedly not ordered by doctors nor used in their treatment.
- Hyderabad police / Shamshabad airport authorities — Monitoring arrivals into the city following information that the accused may be in Hyderabad.
Why it matters
A single laboratory allegedly billing $93 million in genetic tests, with $63 million actually paid out, shows how quickly public health insurance money can be drained through paperwork fraud. The case also underlines the cross-border problem of an accused allegedly fleeing to India while proceedings remain pending abroad, testing surveillance and cooperation between agencies. At the same time, no conviction has been recorded, making the presumption of innocence central to how the story is read.
UPSC angle
Prelims pointers
- Medicare is the US government-funded health insurance programme targeted in the alleged fraud.
- Accused: Khadeer Khan Mohammed (46), owner of American Premier Labs LLC, Richardson, Texas.
- Alleged false claims: about $93 million (over Rs 800 crore); Medicare paid at least $63 million.
- About $13 million in claims were filed in just 10 days; about $6 million seized from his accounts.
- Alleged offence period: August 2023 to October 2024; he is on a Texas fugitive most-wanted list.
- Reportedly in Hyderabad; Shamshabad airport arrivals under police watch; case pending in court.
Mains framing
Healthcare insurance fraud of the kind alleged here works through documentation rather than force: claims for genetic tests that doctors never ordered, filed using physicians' identifying details without consent and in the names of beneficiaries unconnected to them, with the tests playing no role in actual treatment. The scale alleged — about $93 million submitted between August 2023 and October 2024, of which Medicare paid at least $63 million, including $13 million filed in a single ten-day burst — points to weaknesses in real-time claim scrutiny and verification of the ordering physician before reimbursement. Recovery is partial: only about $6 million was seized from accounts under the accused's control, and the accused is reported to have left the US for Hyderabad, turning a domestic fraud case into a cross-border enforcement problem involving fugitive listings and airport-level surveillance. The way forward suggested by the facts lies in tighter pre-payment validation and anomaly detection for high-value diagnostic claims, protection of provider credentials, faster asset attachment, and cooperation between agencies across jurisdictions — while respecting that the case is pending and the accused stands unconvicted and presumed innocent.
Key terms
- Medicare
- US health insurance programme run with government funds, which reimburses providers for approved medical services and tests.
- American Premier Labs LLC
- Genetic testing laboratory in Richardson, Texas, owned by the accused, through which the claims were allegedly submitted.
- Genetic testing claims
- Bills raised for DNA-based diagnostic tests; here allegedly filed without doctors' orders and unused in patient treatment.
- Fugitive most-wanted list
- List of absconding accused maintained by authorities; Texas officials placed Mohammed on it after he allegedly fled the US.
- Medicare reimbursement eligibility
- Conditions a claim must meet to be paid; officials allege ineligible claims were submitted for payment.
Practice questions
- Examine how large-scale health insurance claim fraud is detected and prevented, using the alleged $93 million Medicare genetic testing case as an illustration.
- What challenges arise when an accused in a foreign fraud case is reported to be residing in India, and how can agencies respond within legal limits?
- Discuss the importance of the presumption of innocence in reporting on pending criminal cases involving large financial sums.
Grounded only in the source report — figures and dates are the source's, not inferred.